HDAC9 and cancer: The protein expression level of VEGF, E-cadherin, Vimentin, p-PI3k, p-Akt, and p-mTOR in the cancer cells treated by HDAC inhibitor was significantly reduced compared with the drug-resistant group, along with significantly increased expression level of E-cadherin (P<0.05).